UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Greif Class B
GEF.B
$4.15B
| $944K | ﹤0.01% |
12,342
+3,934
| +47% | +$307K |
|
1977
Sinclair Inc
SBGI
$995M
| $944K | ﹤0.01% |
55,032
+3,993
| +8% | +$69.4K |
|
|
LGF.A
1978
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $943K | ﹤0.01% |
85,210
+16,905
| +25% | +$152K |
|
1979
Sprinklr
CXM
$1.62B
| $942K | ﹤0.01% |
72,692
+27,174
| +60% | +$276K |
|
1980
JFrog
FROG
$10.7B
| $940K | ﹤0.01% |
47,715
-2,074
| -4% | -$46.2K |
|
1981
Ubiquiti
UI
$34.5B
| $935K | ﹤0.01% |
3,443
-3,199
| -48% | -$885K |
|
|
GES
1982
DELISTED
Guess Inc
GES
| $933K | ﹤0.01% |
47,948
+3,335
| +7% | +$71.6K |
|
1983
Beyond Meat
BYND
$268M
| $929K | ﹤0.01% |
+57,255
| New | +$943K |
|
1984
Novavax
NVAX
$1.3B
| $922K | ﹤0.01% |
133,084
+33,652
| +34% | +$310K |
|
1985
American Vanguard Corp
AVD
$65.5M
| $920K | ﹤0.01% |
+42,069
| New | +$907K |
|
1986
Hawkins
HWKN
$2.73B
| $919K | ﹤0.01% |
21,002
+4,965
| +31% | +$201K |
|
1987
Capitol Federal Financial
CFFN
$1.08B
| $912K | ﹤0.01% |
135,560
+10,955
| +9% | +$89K |
|
|
HAYN
1988
DELISTED
Haynes International, Inc.
HAYN
| $912K | ﹤0.01% |
18,204
+2,374
| +15% | +$125K |
|
1989
Victory Capital Holdings
VCTR
$6.85B
| $912K | ﹤0.01% |
31,147
+5,450
| +21% | +$166K |
|
|
BBBY
1990
Bed Bath & Beyond
BBBY
$423M
| $911K | ﹤0.01% |
49,448
+5,139
| +12% | +$95.8K |
|
1991
SiriusPoint
SPNT
$2.63B
| $904K | ﹤0.01% |
111,173
+47,389
| +74% | +$333K |
|
|
HSKA
1992
DELISTED
Heska Corp
HSKA
| $902K | ﹤0.01% |
9,241
| – | – |
|
1993
Vericel Corp
VCEL
$2.25B
| $902K | ﹤0.01% |
30,756
-518
| -2% | -$15K |
|
1994
Pliant Therapeutics
PLRX
$64.4M
| $894K | ﹤0.01% |
33,619
+20,019
| +147% | +$570K |
|
|
EB
1995
DELISTED
Eventbrite
EB
| $889K | ﹤0.01% |
+103,568
| New | +$854K |
|
1996
Ethan Allen Interiors
ETD
$598M
| $888K | ﹤0.01% |
32,345
-7,301
| -18% | -$207K |
|
1997
Scansource
SCSC
$1.1B
| $887K | ﹤0.01% |
29,155
+1,208
| +4% | +$37.5K |
|
|
SHYF
1998
DELISTED
The Shyft Group
SHYF
| $876K | ﹤0.01% |
38,522
+3,008
| +8% | +$84.4K |
|
1999
Enact Holdings
ACT
$6.67B
| $876K | ﹤0.01% |
+38,322
| New | +$912K |
|
2000
Ichor Holdings
ICHR
$2.43B
| $870K | ﹤0.01% |
26,558
+2,459
| +10% | +$78.9K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.